The purpose of this study was to determine the effects of dietary garlic powder on diethylnitrosamine (DEN)-induced hepatocarcinogenesis and cytochrome P450 (CYP) enzymes in weaning male Sprague-Dawley rats by using the medium-term bioassay system of Ito et al. The rats were fed diets that contained 0, 0.5, 2.0 or 5.0% garlic powder for 8 weeks, beginning the diets with the intraperitoneal (i.p.) injection of DEN. The areas of placental glutathione S-transferase (GST-P) positive foci, an effective marker for DEN-initiated lesions, were significantly decreased in the rats that were fed garlicpowder diets; the numbers were significantly decreased only in the 2.0 and 5.0% garlic-powder diets. The pnitrophenol hydroxylase (PNPH) activities and protein levels of CYP 2E1 in the hepatic microsomes of the rats that were fed the 2.0 and 5.0% garlic powder diet were much lower than those of the basal-diet groups. Pentoxyresorufin O-dealkylase (PROD) activity and CYP 2B1 protein level were not influenced by the garlic-powder diets and carcinogen treatment. Therefore, the suppression of CYP 2E1 by garlic in the diet might influence the formation of preneoplastic foci during hepatocarcinogenesis in rats that are initiated with DEN.
Introduction
Liver cancer, one of the most common malignant neoplasms, is a major cause of morbidity and mortality in Japan and Korea (Korea National Statistical Office, 2000) .
Chemoprevention offers an effective means of controlling the incidence of liver cancer. Dietary habits have been reported to significantly modify the initiation, promotion, and progression stages in carcinogenesis (Schorah, 1999) . Garlic (Allium sativum), used extensively as a flavoring agent or spice in foods, exhibits medicinal properties. These include immunomodulatory, hepatoprotective, antioxidant, antimutagenic, and anticarcinogenic effects (Agarwal, 1996) . The anticarcinogenic property of garlic has been documented from both epidemiological and experimental studies. Some, but not all, epidemiological studies have suggested that the consumption of garlic or allium vegetables can decrease cancer incidences in the stomach, esophagus, or colorectus (Fleischauer et al., 2000) . Also, garlic and/or its organosulfur compounds (OSCs) reportedly suppress carcinogen-induced tumors in various organs of animals. These include the mouth (Meng and Shyu, 1990) , esophagus (Wargovich, 1988) , colorectus (Cheng et al., 1995) , breast (Schaffer et al., 1997) , skin (Singh and Shukla, 1998) , and liver (Park and Choi, 1997; Samaranayake et al., 2000) . Therefore, garlic has been proven to possess potent chemopreventive capability to inhibit cancers of various species, organs, or carcinogens.
The mechanism of cancer inhibition by garlic is not clearly understood, but garlic may inhibit cytochrome P450 (CYP) 2E1. This enzyme is involved in the bioformation of various endobiotics and xenobiotics, including drug and environmental carcinogens. Many of the CYP enzymes are inducible by a variety of chemicals. This alteration of the composition of these enzyme systems may have profound effects on chemical toxicity and carcinogenesis (Guengerich et al., 1982) .
Dially sulfide (DAS), one of the garlic OSCs, inhibits chemical toxicity and tumorigenesis in several animal models, presumably by acting as an inhibitor of the CYP-mediated metabolic activation of the toxic and carcinogenic chemicals. DAS seems to cause a selective alteration to certain forms of CYP enzymes in rat liver. For instance, the CYP 2E1 activity (p-nitrophenol hydroxylase, PNPH) and protein level were *To whom correspondence should be addressed. Tel: 82-2-880-6836; Fax: 82-2-877-5170 E-mail: choihm@snu.ac.kr significantly decreased by DAS (Brady et al., 1991; Harber et al., 1994) , DADS (Harber et al., 1994; Siess et al., 1997) , and garlic oil (Kwak et al., 1995) ; whereas, the CYP 2B1 activity (pentoxyresorufin O-dealkylase, PROD) and protein level were induced by DAS (Brady et al., 1991; Harber et al., 1994) and DADS (Harber et al., 1994; Siess et al., 1997) .
However, most of the studies were done short-term by the injection or forced-feeding of several biologically-active constituents that are contained in garlic. Studies on the anticarcinogenic effect and modulation of CYP enzymes with garlic by the dietary route were limited. In addition, the daily doses that were used in these studies were much higher than those that are normally consumed in a human diet (<1 mg OSCs per g garlic). Therefore, in this study, we investigated the effects of dietary garlic powder at various levels on DENinitiated hepatocarcinogenesis and the hepatic microsomal CYP P450 2E1 and P450 2B1 in rats. We used a modified method of the medium-term bioassay system of Ito et al. (1988) . The glutathione S-transferase placental (GST-P) form was used as an enzyme marker of hepatocarcinogenesis (Satoh et al., 1989) . The rats were supplied diets at the levels of 0, 0.5, 2.0, or 5.0% for 8 wks, beginning with the DEN initiation. Garlic powder was added at the level of 0.5, 2.0, or 5.0% to the diet at the expense of corn starch.
Materials and Methods

Animals and diet
At wk 8 after the i.p. injection of DEN, the animals were killed by decapitation after 12 h of fasting. The livers were immediately removed, finely minced in a 50 mM Tris-HCl buffer, pH 7.4, containing 1 mM EDTA, then homogenized. Microsomal and cytosolic fractions were prepared by differential centrifugation, and stored in small aliquots at −70 o C until use.
Immunohistochemical staining for placental glutathione Stransferase (GST-P) positive foci The livers were excised and sections of 2-3 mm thickness were cut with a blade. These liver slices were fixed in ice-cold acetone for the immunohistochemical examination of the GST-P positive foci. The avidin-biotinperoxidase complex method (Vectastain ABC kit, Vector Lab., Burlingame, USA; Hsu et al., 1981 ) was used to demonstrate the GST-P positive liver foci, a putative preneoplastic lesion (Sato et al., 1984) . An immunohistochemical analysis was carried out with sequential treatments of rabbit anti-rat GST-P (MBL Co., Nagoya, Japan) as a primary antibody, goat anti-rabbit IgG antibody as a secondary antibody, and the peroxidase-antiperoxidase complex. Final visualization of the GST-P positive foci was enzymaticallyactivated by 3,3-diaminobenzidine (Sigma Chemical Co.) and H 2 O 2 as substrates. The areas of the GST-P positive foci that were larger than 0.2 mm in diameter were counted. The total areas of the liver sections that were examined were measured using an image analyzer (Quantinet 520; Cambridge Instruments, Cambridge, UK).
Determination of total cytochrome P450 (CYP) content
The total CYP content was determined by the method of Omura and Sato (1964) . Sodium dithionate was added to the fresh liver microsome, and the reduced hemoprotein was combined with carbon monoxide by bubbling CO through the solution. The characteristic absorbance at 450 nm was determined by dual-beam spectroscopy.
p-Nitrophenol hydroxylase (PNPH) assay PNPH was assayed according to Reinke et al. (1985) . The reaction mixtures contained a 100 mM potassium phosphate buffer (pH 6.8), 1.0 mM ascorbic acid, 1 mM NADPH (Sigma Chemical Co.), 1 mg hepatic microsomes, and 100 mM p-nitrophenol (Sigma Chemical Co.) in a total volume of 1.0 ml. The 4-nitrocatechol that was formed was determined spectrophotometrically. Thiobarbituric acid reactive substances (TBARS) assay Lipid peroxides of hepatic microsomes were determined by measuring the formation of TBARS (Buege and Aust, 1978) . Malondialdehyde, as the product of lipid peroxidation, reacted with thiobarbituric acid. The absorbance of the resulting chromophore was measured at 535 nm. Lowry et al. (1951) , using bovine serum albumin as the standard.
Immunoblot analysis A SDS-PAGE analysis was performed according to Laemmli (1970) using the Bio-Rad Mini-protean II apparatus (Bio-Rad Lab., Hercules, UK). Microsomal proteins were separated by 10% SDS-PAGE (Sigma Chemical Co.), and electrophoretically transferred to the Immobilon PVDF transfer membrane (Bio-Rad Lab.), which was immunoblotted with anti- Table 2 . Effects of dietary garlic powder on body weight, liver weight, and relative liver weight in rats that were treated with saline and sham operation (SS) or diethylnitrosamine (DEN) and partial hepatectomy (DEN-PH). The rats were fed 0, 0.5, 2.0 or 5.0% garlicpowder diets for 8 wks.
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Results
In our preliminary feeding trial, the diets that contained 0, 0.5, 2.0, and 5.0% garlic powder did not influence the food intakes and body weight gain in the experimental animals. There was no difference among the groups food intakes during this experimental period. The body weight, liver weight, and relative liver weight (liver weight/body weight ratio) were not significantly influenced by the carcinogen treatment or garlic supplementation ( Table 2 ). The areas of GST-P positive foci of liver in the carcinogentreated rat liver were significantly decreased in all of the garlic powder diet groups when compared to the basal-diet group. The numbers were significantly reduced in the 2.0 and 5.0% garlic-powder diet groups (Fig. 2) .
The total CYP contents in the hepatic microsomes of the control groups were significantly decreased only in the 5.0% garlic powder diet group, while the contents were not influenced by the carcinogen treatment (Table 3) . PNPH activities in the hepatic microsomes of the 2.0 and 5.0% garlic powder diet groups were much lower than those of the basaldiet groups (Table 3) . PROD activities in the hepatic microsomes were not influenced by the garlic supplementation and carcinogen treatment (Table 3) .
The hepatic microsomal G6Pase activity decreased by the carcinogen treatment only in the basal diet group (Table 4) ; the activities of the 2.0 and 5.0% garlic powder diet groups were lower than those of other diet groups among the control groups. There was no difference in the microsomal TBARS contents among the groups (Table 4) .
The CYP 2E1 protein levels in the hepatic microsomes of the 2.0 and 5.0% garlic powder diet groups were much lower than those of the basal diet groups (Fig. 3 (A) ). There was no difference in the protein levels of CYP 2B1 in the hepatic microsomes among the diet groups (Fig. 3 (B) ). 
Discussion
In this study, we examined the effects of dietary garlic powder at various levels on the formation of preneoplastic foci, and the modification of CYP 2E1 in rat livers using a modified method of the medium term bioassay system of Ito et al. (1988) . The medium term bioassay system, which involves the GST-P form as an enzyme marker, was used as the assay method, since it is a specific assay system for preneoplastic lesions that occur during hepatocarcinogenesis (Ito et al., 1988; Satoh et al., 1989) . The 2.0 and 5.0% garlic powder diets were protective against hepatocarcinogenesis, since the areas and numbers of GST-P positive foci were reduced when compared to the other diet groups (Fig. 2) . Garlic powder diets inhibited the pre-initiation, post-initiation, and promotion stages of hepatocarcinogenesis (Park and Choi, 1997; Samaranayake et al., 2000) . Some OSCs by intragastric intubation even promoted hepatocarcinogenesis (Takada et al., 1994; Fukushima et al., 1998) , or DAS and DADS that was administered in the diet and suspended in distilled water, suppressed hepatocarcinogenesis (Jang et al., 1989; HarberMignard et al., 1996) . The reasons for these discrepancies are unclear, but possible explanations include the differences in feeding methods, differences in dosage of garlic or OSCs, or the feeding periods. Feeding the garlic powder as food or in the diet had an inhibitory effect (Park and Choi, 1997; Samaranayake et al., 2000) . However, it was not determined whether or not OSCs were protective, depending on the dosage, feeding method, and organ observed. The dosage of garlic and its OSCs is very important in the feeding experiment, because the oral gavage administration or i.p. injection of a megadose of garlic extracts or garlic oil had harmful and sometimes lethal effects in the organs, such as the esophagus, lung, and liver (Nakagawa et al., 1984; Brady et al., 1991; Alnaqeeb et al., 1996) . In our study, we supplied rats with garlic powder, beginning with the initiation of hepatocarcinogenesis. The diets were continued throughout the promotion stage. There was no significant difference in the final body weight of the basal and garlic diet fed rats (Table  2) . However, the oral intubation and natural consumption of DAS, DADS, and garlic oil significantly decreased the body weight of rats, showing the adverse effects of OSCs and garlic oil (Harber et al., 1994; Sheen et al., 1999) . Therefore, our results indicate that dietary garlic (2.0 and 5.0%) could inhibit DEN-initiated hepatocarcinogenesis, but has no effect on body weight gain and dietary intake.
Garlic is known as an anticarcinogen, because it can modulate the ethanol-inducible CYP 2E1 activity, phase II detoxification system, antioxidant defense system, and/or immune system (Brady et al., 1991; Agarwal, 1996) . In our present study, the 2.0 and 5.0% garlic powder diet clearly suppressed the expression of the CYP 2E1 protein and PNPH activities when compared to the control diet groups (Table 3 , Fig. 3 (A) ). These results are consistent with reports that showed that the forced feeding of DAS, DADS, and garlic oil inhibited CYP 2E1 activities and protein levels (Brady et al., 1991; Kwak et al., 1995; Reicks and Crankshaw, 1996) . Also, dietary garlic powder suppressed the CYP 2E1 in the postinitiation stage of hepatocarcinogenesis (Park and Choi, 1997) .
There was no difference between groups in the PROD activities that reflect the CYP 2B1 activities in hepatic microsomes (Table 3) . Also, the results of immunoblot analyses of hepatic microsomes, using an anti-CYP 2B1 antibody, were not different between the groups (Fig. 3 (B) ). However, DAS and DADS induced the CYP 2B1 protein levels and increased the activities (Brady et al., 1991; Harber et al., 1994) .
Total CYP contents were not influenced by the carcinogen treatment (Table 3) , consistent with some findings that show that the total CYP content was unchanged when the rats were fed DAS, DADS, and garlic oil (Reicks and Crankshaw, 1996; Sheen et al., 1999) . However, the contents in the control groups decreased only in the 5.0% garlic powder diet group when compared to the basal diet group (Table 3) . Similar Table 4 . Effects of dietary garlic powder on glucose 6-phosphatase (G6Pase) activities and thiobarbituric acid reactive substances (TBARS) in rats that were treated with saline and sham operation (SS), or diethylnitrosamine (DEN) and partial hepatectomy (DEN-PH). The rats were fed 0, 0.5, 2.0 or 5.0% garlic powder diets for 8 wks.
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Glucose 6 results were observed when excess OSCs and 5.0% garlicpowder diets were supplied (Harber et al., 1994; Park and Choi, 1997) . It is unclear whether or not the decrease of the total CYP contents is beneficial; however, the total CYP contents were negatively-correlated with areas of GST-P foci in the post-initiation stage of hepatocarcinogenesis (Park and Choi, 1997) . This suggests that there is an optimal dose of garlic to modify the CYP enzymes that has no effect on the total CYP contents. In most of the studies on the modification of CYP enzymes by OSCs and garlic oil, the daily doses that were administered were much higher than those supplied in our study (considering that there is less than 1 mg of OSCs per g garlic). Therefore, it seems important to show that in our study, garlic powder at levels of 2.0 and 5.0% could modify CYP 2E1, but have no effect on CYP 2B1 and the total CYP contents when given by the dietary route. Lipid peroxidation and toxicity that is associated with oxygen radicals have been suggested as major causes of cancer and oxidative stress-related diseases (Park and Choi, 1997; Park et al., 2001) . Also, lipid peroxidation decreased the membrane stability and influenced G6Pase activities (Rowe and Wills, 1976) . The contents of TBARS, an index of lipid peroxidation, were unchanged by garlic and carcinogen (Table 4) , contradictory to the reports that garlic extracts inhibited peroxidation in the carbon tetrachloride-induced liver injury (Kagawa et al., 1986) , and that garlic powder diets suppressed the contents of TBARS in the promotional stage of hepatocarcinogenesis (Park and Choi, 1997) . G6Pase activity, an index of the stability of the microsomal membrane (Kim and Choi, 1994) , decreased in the control groups as the contents of garlic powder increased. Similar result was examined when the 5.0% garlic powder diet was administered in the post-initiation stage of hepatocarcinogenesis (Park and Choi, 1997) . However, there was no difference in the G6Pase activities among the carcinogen-treated groups (Table 4) , and they were not correlated with TBARS, which is consistent with the results of Kweon et al. (2000) . Therefore, garlic powder diets that are supplied with the initiation of hepatocarcinogenesis have no effect on the modulation of G6Pase and TBARS.
Conclusively, the 2.0 and 5.0% garlic powder supplements significantly decreased the area and number of GST-P positive foci, and suppressed the CYP 2E1 activities and protein levels in rats liver carcinogenesis that is initiated by DEN. Therefore, the suppression of CYP 2E1 by dietary garlic powder at levels of 2.0 and 5.0% could influence the preneoplastic foci formation and contribute to chemoprevention against the rat hepatocarcinogenesis. Our data suggest that garlic powder could be effective in inhibiting hepatocarcinogenesis and CYP 2E1, and the regular consumption of garlic may be important for liver cancer prevention.
It is not always clear how laboratory studies can be extrapolated to obtain reasonable consumption levels of garlic or other Allium species for humans. A major concern, which must be addressed when extrapolating animal findings to humans, is the dosage of the food or agent that is studied. Additional studies are warranted on the chemopreventive function. This would include mechanisms, supplementation period, and the practical doses of garlic in diet for human cancer prevention.
